Propelled by interest in all things South Korea, Amorepacific, the cosmetics giant, is expanding its reach into the United ...

Swipe them across your face for a quick refresh, press them onto spots that need extra love, or even layer them like a sheet ...

CJ ENM, one of Korea's leading entertainment and media powerhouses, announced Tuesday that its global K-pop content platform, Mnet Plus, has surpassed 40 million cumulative app users and more than 20 ...

Mirae Asset Global Investments said on the 21st that it will launch the TIGER Korea AI power equipment TOP3 Plus exchange-traded fund (ETF). The TIGER Korea AI power equipment TOP3 Plus ETF ...

SEOUL: Overseas tourists in South Korea continue to move away from traditional Korean restaurants and towards quick, everyday food. A report released on Monday (Oct 20) by the Korea Tourism ...

Dalton Cooper is the Managing Editor of Game Rant. Dalton has been writing about video games professionally since 2011. Having written thousands of game reviews and articles over the course of his ...

Oct. 14 (UPI) --For more than seven decades, diplomats, strategists and scholars have sought to resolve "the Korea question," which is the unnatural division of the peninsula that paragraph 60 of the ...

SBS Plus will present its fourth “special live baseball broadcast,” which will sweep away the aftereffects of October’s golden holiday. SBS Plus will exclusively air the special live broadcast ...

SEOUL: South Korea and the United States have agreed to establish a dedicated “Korean Investor Desk” at the Unied States Embassy in Seoul to address visa issues faced by Korean companies investing in ...

The blistering rally that has added more than $100 billion in market value to South Korea’s two largest chipmakers this month is seen continuing, as the artificial intelligence boom spreads to less ...

Sept. 24 (UPI) --Editor's note: These remarks were provided Tuesday at the Thirty-Ninth International Security Conference: Challenges and Opportunities for the ROK-U.S. Alliance, jointly presented by ...

Angelini Pharma has worked out a $550 million-plus biobucks deal to get its hands on a Korean biotech’s preclinical neuro asset. The deal gives Angelini the option for exclusive licensing rights to ...